
TEM Stock Forecast & Price Target
TEM Analyst Ratings
Bulls say
Tempus AI is poised for future success, driven by sustained profitability, strong financials, and a focus on expanding their capabilities in the MRD space through strategic acquisitions. Their data assets and partnerships with pharmaceutical companies further solidify their competitive advantage and potential for revenue growth. While there are risks to consider, the company's overall outlook is positive and the financial analyst predicts continued growth in revenue and volume.
Bears say
Tempus AI is facing several challenges in its financial performance, including a widening operating loss, lower than expected margins, and cash burn. While the company has shown strong growth in its diagnostics revenue, there are concerns about maintaining this growth as well as the impact of potential changes in healthcare and regulatory environments. Additionally, there is potential for increased competition in the precision medicine space.
This aggregate rating is based on analysts' research of Tempus AI Inc and is not a guaranteed prediction by Public.com or investment advice.
TEM Analyst Forecast & Price Prediction
Start investing in TEM
Order type
Buy in
Order amount
Est. shares
0 shares